EconPapers    
Economics at your fingertips  
 

Cross-over Trials

Byron Jones ()
Additional contact information
Byron Jones: Novartis Pharma AG

Chapter 70 in Principles and Practice of Clinical Trials, 2022, pp 1325-1351 from Springer

Abstract: Abstract Cross-over trials have the potential to provide large reductions in sample size compared to their parallel groups counterparts. In this chapter, three different types of cross-over design and their analysis will be described. In the linear models used to analyze cross-over data, the variability due to differences between the subjects in the trial may be modeled as either fixed or random effects, and both will be illustrated. In designs of the incomplete block type, where there are more treatments than periods, the use of random subject effects enables between-subject information on the treatment comparisons to be recovered, and how this may be done will also be illustrated. Finally, if the so-called baseline measurements have been taken at the beginning of each treatment period, these can be used as covariates to reduce the variability of the estimated treatment comparisons. The use of baselines will be illustrated using the incomplete block design.

Keywords: Crossover trials; Fixed effects; Random effects; Incomplete block; Between-subject information; Baseline information (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-319-52636-2_243

Ordering information: This item can be ordered from
http://www.springer.com/9783319526362

DOI: 10.1007/978-3-319-52636-2_243

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2026-05-22
Handle: RePEc:spr:sprchp:978-3-319-52636-2_243